Prognostic value of apoptotic activity in muscle-invasive bladder cancer

Prognostic value of apoptotic activity in muscle-invasive bladder cancer

nema

Bibliographic Details
Main Authors:	Ristić Ana, Janković-Veličković Ljubinka, Stokanović Dragana
Format:	Article
Language:	English
Published:	Military Health Department, Ministry of Defance, Serbia 2011-01-01
Series:	Vojnosanitetski Pregled
Subjects:	urinary bladder neoplasms apoptosis tumor markers, biological cystoctomy
Online Access:	http://www.doiserbia.nb.rs/img/doi/0042-8450/2011/0042-84501106510R.pdf

Similar Items

Malakoplakia mimics urinary bladder cancer: A case report
by: Ristić-Petrović Ana, et al.
Published: (2013-01-01)

Bladder preservation in muscle-invasive bladder cancer: a comprehensive review
by: Judy Hamad, et al.
Published: (2020-02-01)

Can neutrophil to lymphocyte ratio predict lamina propria invasion in patients with non muscle invasive bladder cancer?
by: Haci Ibrahim Cimen, et al.

Metastatic non-muscle invasive bladder cancer with cervical lymph node metastasis
by: Pablo Garrido-Abad, et al.
Published: (2019-12-01)

Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer
by: Filipe LF. Carvalho, et al.
Published: (2020-07-01)

Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
by: Coleman McFerrin, et al.
Published: (2020-11-01)

Diagnostics techniques in nonmuscle invasive bladder cancer
by: Ayman Soubra, et al.
Published: (2015-01-01)

Endoclips as novel fiducial markers in trimodality bladder-preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient outcomes
by: Muhammad Shahbaz, et al.
Published: (2020-11-01)

Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer?
by: Marco Racioppi, et al.

Progress in bladder cancer research /
by: Mallory, A. M.
Published: (2005)

Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study
by: Vincenzo Favilla, et al.

Cystectomy vs. bladder preservation after neoadjuvant chemotherapy in muscle-invasive bladder cancer: A tertiary medical center experience
by: Ibrahim El Halabi, et al.
Published: (2020-01-01)

Demographic and Survivorship Disparities in Non–muscle-invasive Bladder Cancer in the United States
by: Munseok Seo, et al.
Published: (2018-09-01)

Phenotypic effects of in vitro miR-141 expression modulation in bladder cancer
by: Lai, Jiun Yee
Published: (2013)

Are we following the guidelines on non-muscle invasive bladder cancer?
by: Leonardo Oliveira Reis, et al.
Published: (2016-02-01)

Molecular aspects of bladder cancer
by: Gelbert Luiz Chamon do Carmo Amorim, et al.
Published: (2011-03-01)

Molecular aspects of bladder cancer
by: Gelbert Luiz Chamon do Carmo Amorim, et al.
Published: (2011-03-01)

The Role of Chemotherapy and Radiotherapy in the Surgical Management of Muscle Invasive Bladder Cancer
by: Joshua Luck
Published: (2014-10-01)

Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patients
by: Daniel Au, et al.
Published: (2021-07-01)

The awareness of patients with non - muscle invasive bladder cancer regarding the importance of smoking cessation and their access to smoking cessation programs
by: Emrah Yuruk, et al.

Moderate or severe LUTS is associated with increased recurrence of non - muscle - invasive urothelial carcinoma of the bladder
by: Austin Lunney, et al.

Treatment options in non-muscle-invasive bladder cancer after BCG failure
by: Nathan A Brooks, et al.
Published: (2015-01-01)

Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review
by: Mi Ah Han, et al.
Published: (2021-11-01)

Comparative differences between T1a/b and T1e/m as substages in T1 urothelial carcinoma of the bladder
by: Turgay Turan, et al.

Antiproliferative and apoptotic activity of gemcitabine-lauric acid conjugate on human bladder cancer cells
by: Hongxia Wang, et al.
Published: (2022-04-01)

Invasive bladder cancer in the eighties: transurethral resection or cystectomy?
by: Oscar Rodriguez Faba, et al.
Published: (2011-02-01)

Evaluation of OTX1 as a potential biomarker of bladder cancer
by: Baharudin, Aminuddin
Published: (2018)

Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? Opinion: No
by: Timur Mitin

Stratifying risk for multiple, recurrent, and large (≥3 cm) Ta, G1/G2 tumors in non-muscle-invasive bladder cancer
by: Jungyo Suh, et al.
Published: (2021-07-01)

Presence and predominance of histological grade 3 define cT1HG bladder cancer prognostic groups
by: Leonardo Oliveira Reis, et al.
Published: (2022-01-01)

Identification of Microrna-21 as a Pro-Invasive Taget in Urothelial Cell Carninoma
by: Tan, Keai Sinn
Published: (2011)

Value of MRI in Local Staging of Bladder Cancer
by: Mahyar Ghafoori, et al.
Published: (2013-06-01)

A Study of Lipid- and Protein- Bound Sialic Acids for the Diagnosis of Bladder Cancer and Their Relationships with the Severity of Malignancy
by: Shima Habibi, et al.
Published: (2014-05-01)

Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification
by: Hyeong Dong Yuk, et al.
Published: (2019-09-01)

Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? Opinion: Yes
by: Leonardo L. Monteiro, et al.

Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?
by: Yong-June Kim, et al.
Published: (2016-06-01)

Somatic Mutation of the Non-Muscle-Invasive Bladder Cancer Associated with Early Recurrence
by: Seong Hyeon Yu, et al.
Published: (2023-10-01)

Concurrent Testicular and Bladder Cancer in a 57-year-old Man
by: Esther Han, et al.
Published: (2015-09-01)

Prognostic significance of bladder neck involvement in non‐muscle‐invasive bladder cancer: A SEER database analysis with 19,919 patients
by: Xiangpeng Zhan, et al.
Published: (2021-10-01)

Transition to adulthood with a bladder augmentation: histopathologic concerns
by: Emil Mammadov, et al.